It is well known that the level of expression of PD-L1 on tumor cells correlates with patient prognosis while anti-PD1 immunotherapy has been shown to be successful in many cases (Jiang et al., 2015; Hashimoto et al., 2018; McLane et al., 2019). The gene discussed is CD274; the disease is neoplasm.